Documents reviewing the research on peptides note lack of good evidence of efficacy or safety. Yet an FDA panel will consider easing access to them later this month.
Synthetic peptides, often taken by injection, are growing in popularity among patients seeking to optimize health and longevity. Yet FDA scientists point to a dearth of evidence supporting their use.
Svitlana Pietukhova/iStockphoto/Getty Images
hide caption
toggle caption
Svitlana Pietukhova/iStockphoto/Getty Images
FDA panel on peptides will include experts who promote the unproven chemicals favored by RFK Jr.
RFK Jr. wants to make it easier to get peptides. FDA scientists disagree.
FDA panel on peptides will include experts who promote the unproven chemicals favored by RFK Jr. | CNN
FDA Panel on Peptides Will Include Experts Who Promote the Unproven Chemicals
RFK Jr. stacks FDA panel with peptide peddlers as FDA scientists oppose access
Longevity, wellness physicians named to panel advising FDA on peptides
FDA reviewers oppose allowing seven peptides for compounding
Audio long read: Is the peptide craze backed by science? The promise behind the hype
Compounder Olympia Pharmaceuticals eyes peptide opportunity
A physician examines whether the FDA's loosening of wellness peptide restrictions means these compounds are actually safe and…
The Food and Drug Administration is meeting next month to consider easing restrictions on several peptides, a group of unapproved…
The health secretary has advocated for deregulating certain peptides, but FDA scientists point to a lack of data about their…
When U.S. health officials meet next month to reconsider a list of controversial peptide drugs, they will hear from a new set of…
Several popular peptide injections have been praised by Health Secretary Robert F. Kennedy Jr.
Peptide drugs are popular, but FDA scientists warn they're untested, may be harmful.
